Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
6R-BH4 in Coronary Artery Disease
NCT00423280Phase 2Unknown
- Sponsor
- University of Oxford
- Start
- Nov 2006
- Primary completion
- Feb 2009
- Modality
- Allosteric Modulators, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of sapropterin in coronary artery disease (CAD), sponsored by University of Oxford. Status: unknown.
02
Drugs
sapropterin
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT00423280.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00423280.